Rachel Niederer, University of Michigan RNA Faculty Fall 2022

We are thrilled to announce that Rachel Niederer as agreed to join us as a faculty member in Biological Chemistry, the Center for RNA Biomedicine, and the LSI.

About Dr. Rachel Niederer:
Dr. Niederer completed her undergraduate degree at the University of Maryland, College Park in Biochemistry and Cell Biology/Molecular Genetics where she worked with Dr. Jon Dinman to study the effect of RNA modifications on translational fidelity. She went on to obtain her Ph.D. from John Hopkins under the mentorship of Dr. David Zappula, where she defined shared structural and functional features in telomerase RNA and explored the transcriptional response to telomere loss and senescence. Dr. Niederer carried out postdoctoral studies first with Dr. Melissa Moore at the University of Massachusetts and then (when Dr. Moore moved to Moderna) with Dr. Wendy Gilbert at Yale studying mechanisms of translational control. Rachel developed a novel method to rapidly and quantitatively measure ribosome recruitment to thousands of 5’-UTR sequences to define features controlling translation initiation. This approach, termed Direct Analysis of Ribosome Targeting (DART), published this spring in Cell Systems, has uncovered hundreds of new, functional RNA elements in yeast that differ in their ability to recruit ribosomes and to act as sequence-specific translational repressors.

Future Scientific Plans:
Dr. Niederer’s laboratory will explore mechanisms of translational control. She will bring a new set of cutting-edge approaches for studying translation initiation to the Department of Biological Chemistry, the Center for RNA Biomedicine, and the broader UM community.

If you would like to reach out to welcome Rachel, you may contact her here: rachel.niederer@yale.edu and @roniederer

Similar Posts

|

miR-181a, a microRNA that regulates ovarian cancer cells

by Elisabeth Paymal One of the hallmarks of ovarian cancer is genomic instability resulting in gain and loss of DNA throughout the entire genome, including many microRNAs (miRNA). Dr. DiFeo, Ph.D., Associate Professor of Pathology and of Obstetrics and Gynecology at Michigan Medicine, and her team, research which miRNAs are involved in the early stages…

The RNA Collaborative welcomes its 17th and 18th partners

The RNA Collaborative Seminar Series is pleased to welcome its 17th and 18th partners, the Cambridge RNA Club (UK) and the Groupe de Recherche RNA (GDR RNA – France). The Cambridge RNA Club is an informal seminar series bringing together the RNA community in Cambridge and surrounding areas. The GDR RNA aims to bring together French…

Webinar: “A timely confluence: the backstory of Moderna’s COVID-19 vaccine” by Melissa Moore, February 10, 2021, 4:00– 5:00pm EST

More information and required registration are available here.   Dr. Melissa Moore, chief scientific officer at Moderna Therapeutics, will be hosted for a virtual seminar on February 10, 2021, 4:00– 5:00pm EST by the University of Michigan Center for RNA Biomedicine as part of the worldwide RNA Collaborative Seminar Series. The title of her talk is:…

CRISPR to KLIPP cancer

While most efforts involving CRISPR are focused on genome editing, the CRISPR machinery could also be used as a molecular weapon to slice up chromosomes of cancer cells. Research has shown that chromosomes may undergo a “catastrophic” event early in the process of carcinogenesis causing multiple breakages. While many cells die in such events, some…

The RNA Collaborative celebrates its first year of success!

Launched at the initiative of the University of Michigan Center for RNA Biomedicine, and inaugurated on April 22, 2020, with a seminar hosted by the Yale Center for RNA Science and Medicine, the RNA Collaborative Seminar Series is a growing grassroots effort, now supported by the international RNA Society and involving 21 RNA research partners…

|

Stressed cellular proteins break social distancing rules

By Elisabeth Paymal A team of scientists associated with the University of Michigan Center for RNA Biomedicine discovered unexpected cellular adaptation mechanisms in response to dehydration. The observed protein reaction has never been reported before. The research began while observing processing bodies (P-Bodies), which are membrane-less organelles (MLO) involved in RNA degradation in human cells….